Genotypes other than A1/A1 which may have more activity for CYP17 enzyme for estrogen metabolism (A1/A2, A2/A2) were more frequent among younger breast cancer patients compared to older ones and this was statistically significant (P=0.02). This evidence concerns the gene CYP17A1 and breast carcinoma.